Huifang Zhou

Huifang Zhou


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Carbohydrate Polymers
Verified
Journal Article
Closed access
PZPing Zhao
Ping Zhao
HZHuifang Zhou
Huifang Zhou
CZChengcheng Zhao
Chengcheng Zhao
XLXia Li
Xia Li
YWYing Wang
Ying Wang
WGWenyuan Gao
Wenyuan Gao

13 April 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
LPLisa Dal Pozzo
Lisa Dal Pozzo
ZXZhe Xu
Zhe Xu
SLShan Lin
Shan Lin
JWJida Wang
Jida Wang
YWYing Wang
Ying Wang
YBYuhong Bian
Yuhong Bian
Multiple epigenetic factors play a regulatory role in maintaining the homeostasis of cutaneous components and are implicated in the aging process of the skin. They have been associated with the activation of the senescence program, which is the primary contributor to age-related decline in the skin. Senescent species drive a series of interconnected processes that impact the immediate surroundings, leading to structural changes, diminished functionality, and heightened vulnerability to infections. Geroprotective medicines that may restore the epigenetic balance represent valid therapeutic alliances against skin aging. Most of them are well-known Western medications such as metformin, nicotinamide adenine dinucleotide (NAD+), rapamycin, and histone deacetylase inhibitors, while others belong to Traditional Chinese Medicine (TCM) remedies for which the scientific literature provides limited information. With the help of the Geroprotectors.org database and a comprehensive analysis of the referenced literature, we have compiled data on compounds and formulae that have shown potential in preventing skin aging and have been identified as epigenetic modulators.

23 August 2023 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
ZXZhe Xu
Zhe Xu
BGBoyang Gong
Boyang Gong
ZLZhaodong Li
Zhaodong Li
YWYing Wang
Ying Wang
ZZZeyu Zhao
Zeyu Zhao
YBYuhong Bian
Yuhong Bian
Bazi Bushen, a Chinese‐patented drug with the function of relieving fatigue and delaying ageing, has been proven effective for extenuating skin senescence. To investigate the potential mechanism, senescence‐accelerated mouse prone 6 (SAMP6) was intragastrically administered with Bazi Bushen for 9 weeks to induce skin homeostasis. Skin homeostasis is important in mitigating skin senescence, and it is related to many factors such as oxidative stress, SASP, apoptosis, autophagy and stem cell. In our study, skin damage in SAMP6 mice was observed using HE, Masson and SA‐β‐gal staining. The content of hydroxyproline and the activities of SOD, MDA, GSH‐PX and T‐AOC in the skin were measured using commercial assay kits. The level of SASP factors (IL‐6, IL‐1β, TNF‐α, MMP2 and MMP9) in skin were measured using ELISA kits. The protein expressions of p16, p21, p53, Bax, Bcl‐2, Cleaved caspase‐3, LC3, p62, Beclin1, OCT4, SOX2 and NANOG were measured by western blotting. The expression of ITGA6 and COL17A1 was measured by immunofluorescence staining and western blotting. Our findings demonstrated that Bazi Bushen alleviated skin senescence by orchestrating skin homeostasis, reducing the level of oxidative stress and the expression of SASP, regulating the balance of apoptosis and autophagy and enhancing the protein expressions of ITGA6 and COL17A1 to improve skin structure in SAMP6 mice. This study indicated that Bazi Bushen could serve as a potential therapy for alleviating skin senescence.